Company · CIK 1403708
Evoke Pharma Inc
| CIK | 1403708 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2013-11-13 |
Offerings
7 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-200176 | 2014-11-13 | 2025-12-18 | 10 | |
| 333-221556 | 2017-11-14 | 2025-12-18 | 3 | |
| 333-251614 | 2020-12-22 | 2025-12-18 | 6 | |
| 333-275443 | 2023-11-09 | 2025-12-18 | 9 | |
| 333-281527 | 2024-08-13 | 2025-12-18 | 3 | |
| 333-281840 | 2024-08-29 | 2025-12-18 | 4 | |
| 333-188838 | 2013-05-24 | 2013-09-25 | 7 |
Filings
43| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-12-18 | EFFECTDeclared effective | 333-281840 | 9999999995-25-003825 |
| 2025-12-18 | EFFECTDeclared effective | 333-281527 | 9999999995-25-003824 |
| 2025-12-18 | EFFECTDeclared effective | 333-275443 | 9999999995-25-003821 |
| 2025-12-18 | EFFECTDeclared effective | 333-251614 | 9999999995-25-003819 |
| 2025-12-18 | EFFECTDeclared effective | 333-221556 | 9999999995-25-003818 |
| 2025-12-18 | EFFECTDeclared effective | 333-200176 | 9999999995-25-003817 |
| 2024-11-22 | 424B5Shelf takedown | 333-281840 | 0000950170-24-130258 |
| 2024-09-06 | EFFECTDeclared effective | 333-281840 | 9999999995-24-002745 |
| 2024-08-29 | S-3Shelf registered | 333-281840 | 0000950170-24-101877 |
| 2024-08-21 | EFFECTDeclared effective | 333-281527 | 9999999995-24-002597 |
| 2024-08-13 | S-3Shelf registered | 333-281527 | 0000950170-24-096331 |
| 2024-02-09 | 424B4Final prospectus | 333-275443 | 0000950170-24-013376 |
| 2024-02-08 | EFFECTDeclared effective | 333-275443 | 9999999995-24-000351 |
| 2024-02-08 | S-1/AAmendment | 333-275443 | 0000950170-24-012532 |
| 2024-01-11 | S-1/AAmendment | 333-275443 | 0000950170-24-003749 |
| 2024-01-04 | S-1/AAmendment | 333-275443 | 0000950170-24-001911 |
| 2023-12-19 | S-1/AAmendment | 333-275443 | 0000950170-23-071283 |
| 2023-12-15 | S-1/AAmendment | 333-275443 | 0000950170-23-070779 |
| 2023-11-09 | S-1Registration filed | 333-275443 | 0000950170-23-062129 |
| 2022-04-26 | 424B5Shelf takedown | 333-251614 | 0001193125-22-120479 |
| 2021-01-14 | 424B5Shelf takedown | 333-251614 | 0001193125-21-009159 |
| 2021-01-13 | 424B5Shelf takedown | 333-251614 | 0001193125-21-008177 |
| 2021-01-06 | EFFECTDeclared effective | 333-251614 | 9999999995-21-000054 |
| 2020-12-22 | S-3Shelf registered | 333-251614 | 0001193125-20-324700 |
| 2017-12-28 | EFFECTDeclared effective | 333-221556 | 9999999995-17-003343 |
| 2017-11-14 | S-3Shelf registered | 333-221556 | 0001193125-17-342602 |
| 2017-03-10 | 424B5Shelf takedown | 333-200176 | 0001193125-17-078954 |
| 2017-02-16 | 424B5Shelf takedown | 333-200176 | 0001193125-17-046708 |
| 2017-02-15 | 424B5Shelf takedown | 333-200176 | 0001193125-17-045464 |
| 2016-08-01 | 424B5Shelf takedown | 333-200176 | 0001193125-16-666559 |
| 2016-07-22 | 424B5Shelf takedown | 333-200176 | 0001193125-16-655244 |
| 2016-07-20 | 424B5Shelf takedown | 333-200176 | 0001193125-16-651770 |
| 2016-04-15 | 424B5Shelf takedown | 333-200176 | 0001193125-16-543245 |
| 2014-11-25 | EFFECTDeclared effective | 333-200176 | 9999999995-14-003515 |
| 2014-11-13 | S-3Shelf registered | 333-200176 | 0001193125-14-411177 |
| 2013-09-25 | 424B4Final prospectus | 333-188838 | 0001193125-13-378478 |
| 2013-09-24 | EFFECTDeclared effective | 333-188838 | 9999999995-13-002760 |
| 2013-08-30 | S-1/AAmendment | 333-188838 | 0001193125-13-354102 |
| 2013-08-16 | S-1/AAmendment | 333-188838 | 0001193125-13-338193 |
| 2013-07-03 | S-1/AAmendment | 333-188838 | 0001193125-13-282883 |
| 2013-06-14 | S-1/AAmendment | 333-188838 | 0001193125-13-259742 |
| 2013-05-24 | S-1Registration filed | 333-188838 | 0001193125-13-235439 |
| 2013-04-19 | DRSDraft made public | 377-00160 | 0000950123-13-002398 |